STAT | Reporting from the frontiers of health and medicine Follow STAT+: Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound Prominent biotech VC firm Atlas Venture has another $400 million to invest in drug companies. https://www.statnews.com/2025/09/04/atlas-venture-biotech-opportunity-fund/ statnews.com
